184 related articles for article (PubMed ID: 33516580)
21. Pain Response After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases-A Phase 2 Randomized Controlled Trial Within a Prospective Cohort.
Pielkenrood BJ; van der Velden JM; van der Linden YM; Bartels MMT; Kasperts N; Verhoeff JJC; Eppinga WSC; Gal R; Verlaan JJ; Verkooijen HML
Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):358-367. PubMed ID: 33333200
[TBL] [Abstract][Full Text] [Related]
22. Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control.
Stinauer MA; Kavanagh BD; Schefter TE; Gonzalez R; Flaig T; Lewis K; Robinson W; Chidel M; Glode M; Raben D
Radiat Oncol; 2011 Apr; 6():34. PubMed ID: 21477295
[TBL] [Abstract][Full Text] [Related]
23. Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I/II trials.
Ghia AJ; Chang EL; Bishop AJ; Pan HY; Boehling NS; Amini B; Allen PK; Li J; Rhines LD; Tannir NM; Tatsui CE; Brown PD; Yang JN
J Neurosurg Spine; 2016 May; 24(5):829-36. PubMed ID: 26799117
[TBL] [Abstract][Full Text] [Related]
24. Dose-Escalated 2-Fraction Spine Stereotactic Body Radiation Therapy: 28 Gy Versus 24 Gy in 2 Daily Fractions.
Zeng KL; Abugarib A; Soliman H; Myrehaug S; Husain ZA; Detsky J; Ruschin M; Karotki A; Atenafu EG; Larouche J; Campbell M; Maralani P; Sahgal A; Tseng CL
Int J Radiat Oncol Biol Phys; 2023 Mar; 115(3):686-695. PubMed ID: 36309076
[TBL] [Abstract][Full Text] [Related]
25. Is SBRT Boost Feasible for PET Positive Lymph Nodes for Cervical Cancer? Evaluation using Tumor Control Probability and QUANTEC Criteria.
Snyder JE; Willett AB; Sun W; Kim Y
Pract Radiat Oncol; 2019 Mar; 9(2):e156-e163. PubMed ID: 30415074
[TBL] [Abstract][Full Text] [Related]
26. Stereotactic body radiation therapy in spinal metastases.
Ahmed KA; Stauder MC; Miller RC; Bauer HJ; Rose PS; Olivier KR; Brown PD; Brinkmann DH; Laack NN
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e803-9. PubMed ID: 22330988
[TBL] [Abstract][Full Text] [Related]
27. Imaging-Based Outcomes for 24 Gy in 2 Daily Fractions for Patients with de Novo Spinal Metastases Treated With Spine Stereotactic Body Radiation Therapy (SBRT).
Tseng CL; Soliman H; Myrehaug S; Lee YK; Ruschin M; Atenafu EG; Campbell M; Maralani P; Yang V; Yee A; Sahgal A
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):499-507. PubMed ID: 30003994
[TBL] [Abstract][Full Text] [Related]
28. Modeling of Tumor Control Probability in Stereotactic Body Radiation Therapy for Adrenal Tumors.
Stumpf PK; Yorke ED; El Naqa I; Cuneo KC; Grimm J; Goodman KA
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):217-226. PubMed ID: 33864824
[TBL] [Abstract][Full Text] [Related]
29. A Phase 2 Study of Post-Operative Stereotactic Body Radiation Therapy (SBRT) for Solid Tumor Spine Metastases.
Redmond KJ; Sciubba D; Khan M; Gui C; Lo SL; Gokaslan ZL; Leaf B; Kleinberg L; Grimm J; Ye X; Lim M
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):261-268. PubMed ID: 31628959
[TBL] [Abstract][Full Text] [Related]
30. Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer.
Guckenberger M; Klement RJ; Allgäuer M; Appold S; Dieckmann K; Ernst I; Ganswindt U; Holy R; Nestle U; Nevinny-Stickel M; Semrau S; Sterzing F; Wittig A; Andratschke N; Flentje M
Radiother Oncol; 2013 Oct; 109(1):13-20. PubMed ID: 24183066
[TBL] [Abstract][Full Text] [Related]
31. Calculating the individualized fraction regime in stereotactic body radiotherapy for non-small cell lung cancer based on uncomplicated tumor control probability function.
Lu JY; Lin PX; Huang BT
Radiat Oncol; 2019 Jun; 14(1):111. PubMed ID: 31221159
[TBL] [Abstract][Full Text] [Related]
32. Correlation of clinical outcome, radiobiological modeling of tumor control, normal tissue complication probability in lung cancer patients treated with SBRT using Monte Carlo calculation algorithm.
Sood SS; Pokhrel D; Badkul R; TenNapel M; McClinton C; Kimler B; Wang F
J Appl Clin Med Phys; 2020 Oct; 21(10):56-62. PubMed ID: 32794632
[TBL] [Abstract][Full Text] [Related]
33. Normal tissue complication probability of vertebral compression fracture after stereotactic body radiotherapy for de novo spine metastasis.
Chen X; Gui C; Grimm J; Huang E; Kleinberg L; Lo L; Sciubba D; Khan M; Redmond KJ
Radiother Oncol; 2020 Sep; 150():142-149. PubMed ID: 32540335
[TBL] [Abstract][Full Text] [Related]
34. Stereotactic radiosurgery for treatment of spinal metastases recurring in close proximity to previously irradiated spinal cord.
Choi CY; Adler JR; Gibbs IC; Chang SD; Jackson PS; Minn AY; Lieberson RE; Soltys SG
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):499-506. PubMed ID: 20133079
[TBL] [Abstract][Full Text] [Related]
35. Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review.
Myrehaug S; Sahgal A; Hayashi M; Levivier M; Ma L; Martinez R; Paddick I; Régis J; Ryu S; Slotman B; De Salles A
J Neurosurg Spine; 2017 Oct; 27(4):428-435. PubMed ID: 28708043
[TBL] [Abstract][Full Text] [Related]
36. Stereotactic body radiotherapy is effective salvage therapy for patients with prior radiation of spinal metastases.
Sahgal A; Ames C; Chou D; Ma L; Huang K; Xu W; Chin C; Weinberg V; Chuang C; Weinstein P; Larson DA
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):723-31. PubMed ID: 19095374
[TBL] [Abstract][Full Text] [Related]
37. Long-Term Outcomes After Stereotactic Radiosurgery for Spine Metastases: Radiation Dose-Response for Late Toxicity.
Ling DC; Flickinger JC; Burton SA; Heron DE; Quinn AE; Bejjani GK; Engh JA; Gerszten PC; Amankulor NM; Vargo JA
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):602-609. PubMed ID: 29678526
[TBL] [Abstract][Full Text] [Related]
38. Oligometastatic Disease State Is Associated with Improved Local Control in Patients Undergoing Three or Five Fraction Spine Stereotactic Body Radiotherapy.
Silva SR; Gliniewicz A; Martin B; Prabhu VC; Germanwala AV; Melian E; Jones GA; Solanki AA
World Neurosurg; 2019 Feb; 122():e342-e348. PubMed ID: 30326310
[TBL] [Abstract][Full Text] [Related]
39. Single fraction spine stereotactic ablative body radiotherapy with volumetric modulated arc therapy.
Gestaut MM; Thawani N; Kim S; Gutti VR; Jhavar S; Deb N; Morrow A; Ward RA; Huang JH; Patel M
J Neurooncol; 2017 May; 133(1):165-172. PubMed ID: 28409420
[TBL] [Abstract][Full Text] [Related]
40. Outcomes for Spine Stereotactic Body Radiation Therapy and an Analysis of Predictors of Local Recurrence.
Bishop AJ; Tao R; Rebueno NC; Christensen EN; Allen PK; Wang XA; Amini B; Tannir NM; Tatsui CE; Rhines LD; Li J; Chang EL; Brown PD; Ghia AJ
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1016-1026. PubMed ID: 26025777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
